BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.2466.67%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 7.39% | 0.44% | 0.62% | -0.26% | -7.34% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 7.39% | 0.44% | 0.62% | -0.26% | -7.34% |
Operating Income | -7.39% | -0.44% | -0.62% | 0.26% | 7.34% |
Income Before Tax | -7.39% | -0.44% | -0.62% | 0.26% | 7.34% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -7.39% | -0.44% | -0.62% | 0.26% | 7.34% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -7.39% | -0.44% | -0.62% | 0.26% | 7.34% |
EBIT | -7.39% | -0.44% | -0.62% | 0.26% | 7.34% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -7.69% | 0.00% | -2.27% | 0.00% | 7.14% |
Normalized Basic EPS | -8.33% | 0.00% | 0.00% | 0.00% | 7.69% |
EPS Diluted | -7.69% | 0.00% | -2.27% | 0.00% | 7.14% |
Normalized Diluted EPS | -8.33% | 0.00% | 0.00% | 0.00% | 7.69% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |